Pfizer and Biontech sue Moderna over Corona vaccine patent

sueddeutsche.de/wirtschaft/impfstoffe-medikamente-biontech-patentklagen-1.5710442

Dec 06 22

Patents: Biontech sues Moderna: The Mainz-based company rejects accusations that it has infringed patents. It is just one of many lawsuits ...

0

20

More news on this subject

Reuters

A

Dec 06 22

Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents: Pfizer Inc (PFE.N) and its German partner, BioNTech SE (22UAy.DE), fired back at Moderna Inc ...

reuters.com/legal/pfizer-biontech-countersue-moderna-over-covid-19-vaccine-patents-2022-12-05/

15

15 20

Der Standard

C+

Dec 06 22

Pfizer and Biontech sue Moderna over Corona vaccine patent: In the United States, a lawsuit filed by Moderna has been dismissed. In addition ...

derstandard.at/story/2000141542467/pfizer-und-biontech-klagen-moderna-wegen-corona-impfstoffpatent

0

2

Süddeutsche Zeitung

sueddeutsche.de/wirtschaft/impfstoffe-medikamente-biontech-patentklagen-1.5710442

Dec 06 22

Patents: Biontech sues Moderna: The Mainz-based company rejects accusations that it has infringed patents. It is just one of many lawsuits ...

0

20

faz.net/aktuell/wirtschaft/unternehmen/biontech-und-pfizer-wehren-sich-gegen-moderna-klage-18513142.html

Dec 06 22

Vaccine makers clash: Pfizer and Biontech defend against Moderna lawsuit.: The major mRNA pioneers are in a legal battle over patents. With a countersuit ...

0

53

Der Spiegel (online)

spiegel.de/wirtschaft/unternehmen/corona-patent-biontech-startet-gegenangriff-gegen-moderna-a-8062368d-a28d-4bf7-83bd-201a1698af47

Dec 06 22

Vaccine patent dispute: Pfizer and Biontech launch counterattack against Moderna.

0

5

St. Louis Post-Dispatch

B+

Dec 06 22

Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents: Moderna first sued Pfizer in August.

stltoday.com/lifestyles/health-med-fit/coronavirus/pfizer-biontech-countersue-moderna-over-covid-19-vaccine-patents/article_b561d889-fae3-532a-8516-07e3aef496b2.html

0

2

faz.net/aktuell/wirtschaft/unternehmen/pfizer-und-biontech-wehren-sich-gegen-moderna-klage-18513142.html

Dec 06 22

Vaccine makers argue: Pfizer and Biontech defend against Moderna lawsuit: The great mRNA pioneers are in legal battles over patents. With a counterclaim ...

0

5

nord24 Dec 06 22

Mobile vaccination teams of the district of Cuxhaven go on farewell tour: Just like everywhere else in Lower Saxony, the mobile vaccination teams in Cuxhaven ...

nord24.de/landkreis-cuxhaven/mobile-impfteams-des-kreises-cuxhaven-gehen-auf-abschiedstour-104970.html

0

43

mittelhessen.de

mittelhessen.de/wirtschaft/wirtschaft-ueberregional/patentstreit-mit-moderna-biontech-schlagt-zuruck-und-klagt--2136973_25857591

Dec 06 22

Patent dispute with Moderna: Biontech strikes back and sues: After the huge success of the corona vaccine, competitors are suing Biontech with patent lawsuits ...

allgemeine-zeitung.de/wirtschaft/wirtschaft-ueberregional/patentstreit-mit-moderna-biontech-schlagt-zuruck-und-klagt--2136973_25857591

0

allgemeine-zeitung.de

B-

Dec 06 22

Patent dispute with Moderna: Biontech strikes back and sues: After the huge success of the corona vaccine, competitors are suing Biontech with patent lawsuits ...

wiesbadener-kurier.de/wirtschaft/wirtschaft-ueberregional/patentstreit-mit-moderna-biontech-schlagt-zuruck-und-klagt--2136973_25857591

0

wiesbadener-kurier.de

B-

Dec 06 22

Patent dispute with Moderna: Biontech strikes back and sues: After the huge success of the corona vaccine, competitors are suing Biontech with patent lawsuits ...

0

echo-online.de

echo-online.de/wirtschaft/wirtschaft-ueberregional/patentstreit-mit-moderna-biontech-schlagt-zuruck-und-klagt--2136973_25857591

Dec 06 22

Patent dispute with Moderna: Biontech strikes back and sues: After the huge success of the corona vaccine, competitors are suing Biontech with patent lawsuits ...

0

DER AKTIONÄR

deraktionaer.de/artikel/pharma-biotech/biontech-und-moderna-gruenes-licht-und-neue-klage-20322342.html

Dec 07 22

BioNTech and Moderna: Green light and new lawsuit: Adapted corona vaccines from BioNTech/Pfizer and Moderna, which have so far only been used as booster ...

0

DER AKTIONÄR

deraktionaer.de/artikel/pharma-biotech/biontech-konkurrent-moderna-showdown-naht-20322191.html

Dec 05 22

BioNTech competitor Moderna: Showdown is near: The biotech forge Moderna has made a name for itself worldwide with the development of its corona vaccine Spikevax

0

T-Online Apr 05

Stefan Homburg: CDU Council invites Schwurbel professor to give a lecture: The CDU Economic Council invites you to a lecture with a professor who is notorious ...

t-online.de/nachrichten/deutschland/gesellschaft/id_100378778/stefan-homburg-cdu-rat-laedt-schwurbel-professor-zum-vortrag.html

Quick Glance: Stefan Homburg: Controversy Surrounding Lecture at Business Council

The CDU's Business Council invites controversial Professor Stefan Homburg, known for spreading misinformation about Corona.

Homburg, once a respected expert, faced criticism due to questionable statements during the pandemic.

The decision to invite Homburg sparks outrage and criticism for his controversial views, especially upsetting cancer patients.

The Business Council, a lobbying organization with ties to the CDU, faces scrutiny for organizing influential supporters and attracting backlash over the invitation.

Capital (German magazine)

686

0

capital.de/geld-versicherungen/biontechs-geschaeft-bricht-massiv-ein--aktie-jetzt-guenstig-kaufen--34561014.html

Mar 20

Biontech's business collapses massively: buy shares cheaply now?: Corona is over, and the numbers and share price at vaccine manufacturer Biontech are collapsing ...

Quick Glance: Biontech: Massive Business Decline Post-COVID

As COVID ends, Biontech faces declining numbers and stock prices.

A study reveals the significant impact of COVID on life expectancy.

Biontech gained global recognition with the mRNA vaccine.

The company is now focusing on new treatments for cancer to bounce back.

133

98

faz.net/aktuell/wirtschaft/unternehmen/biontech-fokussiert-auf-krebstherapien-19599944.html

Mar 20

mRNA pioneer: Biontech focuses on cancer therapies: The Mainz mRNA pioneer is doing well in the declining Corona business. However, the focus is clearly on the ...

Quick Glance: BioNTech Focuses on Cancer Drug Development after Revenue Plunge

BioNTech reported a significant drop in revenue and earnings in 2023 as it shifts focus towards cancer drug development.

The company aims for revenues between 2.5 billion to 3.1 billion euros in 2024.

BioNTech plans to launch its first oncology drug in 2026 and secure ten indication approvals by 2030.

Partner Pfizer anticipates a decline in sales for the COVID-19 vaccine, while BioNTech invests in scaling up its oncology business.

19 similar articles

28

7 0

wiesbadener-kurier.de

B-

Apr 05

Biontech is probably in the red this year: Biontech could end a financial year with losses in 2024 for the first time since the pandemic ...

wiesbadener-kurier.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-schreibt-dieses-jahr-wohl-rote-zahlen-3464126

Quick Glance: Biontech: Financial Situation and Product Portfolio

Biontech is expected to slip into the red this year. Indications suggest that losses will be incurred.

Biontech launched an immunization campaign half a year ago in Mainz with posters encouraging medical consultation.

The company holds product aces, including vaccines and treatments combating diseases.

The financial status reflects predicted losses despite an array of promising products.

35

Apr 12

Moderna pauses Kenya plant plans as COVID vaccine demand wanes: Moderna said on Thursday it had paused its plans to build a vaccine manufacturing facility in ...

reuters.com/business/healthcare-pharmaceuticals/moderna-puts-kenya-plant-plans-hold-covid-vaccine-demand-slumps-2024-04-11/

182

Mar 24

Sick after coronavirus vaccination? Palatinate man goes to court: A man from Pirmasens takes Biontech to court. Because he has suffered serious damage to his ...

rheinpfalz.de/lokal/pirmasens_artikel,-krank-nach-corona-impfung-pf%C3%A4lzer-zieht-vor-gericht-_arid,5628342.html

65

40

faz.net/aktuell/rhein-main/frankfurt/corona-impfungen-verfahren-gegen-biontech-wegen-vermeintlicher-impfschaeden-19469214.html

Jan 24

Alleged vaccine damage: First proceedings opened in Hesse against Biontech: Vaccinated people all over Germany are suing pharmaceutical companies because of ...

rnd.de/panorama/herzschaden-durch-corona-impfung-klage-gegen-biontech-abgewiesen-HINPVMMAQ5KPBBIK7472V4DVAU.html

Quick Glance: Lawsuit Against Biontech for Alleged Vaccine Injuries

Vaccinated individuals across Germany are suing pharmaceutical companies for alleged vaccine injuries.

The first lawsuit against Biontech in Hessen has commenced in Frankfurt.

The Frankfurt Regional Court heard a civil lawsuit against vaccine manufacturer Biontech on Tuesday.

Lawyers represent nearly 3000 cases of alleged vaccine injuries and lawsuits.

1 similar article

327

133

Leipziger Volkszeitung

B

Feb 14

Heart damage due to coronavirus vaccination? Lawsuit against Biontech dismissed: One plaintiff claimed to have suffered health problems as a result of the ...

Quick Glance: Lawsuit against Biontech Dismissed

Woman sought 150,000 euros in damages from Biontech.

Court rejects lawsuit over alleged vaccine injuries.

Plaintiff claimed heart damage from vaccination.

Landgericht Frankfurt rules against damages claim.

55

Jan 30

Corona: Low demand for vaccines causes a massive drop in profits at Pfizer: Last year, demand for corona drugs fell significantly. The US group's revenue fell by ...

berliner-zeitung.de/news/corona-geringe-impfstoff-nachfrage-sorgt-fuer-massiven-gewinneinbruch-bei-pfizer-li.2182119

fr.de/politik/rki-protokolle-robert-koch-institut-corona-coronavirus-impfung-astrazeneca-zr-92921607.html

127

44

Frankfurter Rundschau

C+

Apr 01

RKI doubted AstraZeneca for months: “Less perfect”, “not a sure-fire success”, “2-class vaccination”

7

Apr 15

Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales

qz.com/novavax-covid19-mrna-1851410267

Quick Glance: Criticism of Novavax for Missed Opportunities in Boosting COVID-19 Vaccine Sales

Shah Capital called for immediate changes in the company's board.

The activist hedge fund Shah Capital criticized Novavax's leadership for not capitalizing on concerns some individuals have about mRNA vaccines to increase sales of its traditional, protein-based COVID-19 vaccine.

Findings from a survey of 1,500 Americans by the Annenberg Public Policy Center (APPC) at the University of Pennsylvania revealed an increase in the spread of vaccine misinformation.

The limited use of COVID-19 vaccines is also affecting other vaccine manufacturers. In the U.S., only 14% of adults have received an updated COVID-19 vaccine for 2023-2024, according to the Centers for Disease Control and Prevention.

0

Jan 31

BioNTech co-founder Christoph Huber: “Threat was stylized instead of clarified” | Tyrolean daily newspaper online

tt.com/artikel/30874945/biontech-mitgruender-christoph-huber-bedrohung-wurde-stilisiert-statt-aufzuklaeren

5

Jan 16

Biotech production: Wuxi is competing with Lonza and Siegfried: As a partner of Moderna, Lonza ensured the rapid production of vaccines during the pandemic ...

nzz.ch/meinung/biotech-produktion-wuxi-macht-lonza-und-siegfried-konkurrenz-ld.1773757

5

Apr 11

Moderna pauses Kenya plant plans as COVID vaccine demand wanes: Moderna said on Thursday it had paused its plans to build a vaccine manufacturing facility in ...

reuters.com/business/healthcare-pharmaceuticals/moderna-puts-kenya-plant-plans-hold-covid-vaccine-demand-slumps-2024-04-11/

7 similar articles

0

0 34

SeekingAlpha Apr 16

Pfizer's Doldrums, Just A Bad Case Of COVID-19?: Pfizer may be worth buying as the COVID-based product revenues decline and equilibrate ...

seekingalpha.com/article/4683994-pfizer-doldrums-just-a-bad-case-of-covid-19-pfe-stock

0

Mar 18

German biotechs: CureVac hits the brakes, BioNTech faces an important date: CureVac plans to cut 150 jobs to focus on broader product pipeline.

deraktionaer.de/artikel/pharma-biotech/deutsche-biotechs-curevac-tritt-auf-die-bremse-biontech-vor-wichtigem-termin-20353214.html

0

Financial Times

ft.com/content/77f1be71-dc25-48df-8f9a-f677e2cf07a6

Mar 12

The UK could be a vaccine superpower, but it needs a booster: We risk forgetting the lessons of the Covid pandemic

0

8

faz.net/aktuell/wirtschaft/unternehmen/deutsche-biotechs-mit-trendwende-nach-corona-flaute-die-aussichten-fuer-2024-19441743.html

Jan 15

Financing: German biotechs raise one billion euros: The lull after the Corona boom seems to be over: in 2023, German biotechs raised more money from investors ...